Trial intelligence / Profile preview

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

NCT01898221Phase 3Completed

Sponsor
Houston Methodist Research Institute
Start
Oct 2013
Primary completion
Dec 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ethanol in Atrial fibrillation (AFib), sponsored by Houston Methodist Research Institute. Started Oct 2013; status: completed.

02

Drugs

ethanol
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT01898221.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01898221.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call